Location History:
- Taipei, TW (2001)
- Hsin Yi Dist., Taipei, TW (2001)
Company Filing History:
1 out of 534 
1 out of 25 Years Active: 2001-2025
Title: Yu Chen Lin: Innovator in Saponin Adjuvant Technology
Introduction
Yu Chen Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of adjuvants for vaccines. With a total of 3 patents to his name, Lin's work is recognized for its innovative approaches and practical applications.
Latest Patents
One of Lin's latest patents is focused on a saponin adjuvant and its evaluation method. This patent details the six isomer structures of isolated OBI-821 adjuvant, specifically OBI-821-1990-V1A, OBI-821-1990-V1B, OBI-821-1990-V2A, OBI-821-1990-V2B, OBI-821-1858-A, and OBI-821-1858-B. The method for evaluating the quality of these isomers employs hydrophilic interaction liquid chromatography (HILIC) and reverse phase high performance liquid chromatography (RP-HPLC). This innovative approach allows for the effective separation of the isomers, thereby enhancing the quality assessment of the OBI-821 adjuvant.
Career Highlights
Throughout his career, Yu Chen Lin has worked with several prominent companies, including Asia Vital Components Co., Ltd. and Obi Pharma Inc. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Lin has collaborated with notable colleagues, including Cheng-Der Tony Yu and Yih-Huang Hsieh. These partnerships have further enriched his research and development efforts in the pharmaceutical sector.
Conclusion
Yu Chen Lin's contributions to the field of saponin adjuvants demonstrate his commitment to advancing pharmaceutical technology. His innovative patents and collaborations highlight his role as a key figure in the industry.